万泰生物：第六届董事会第十四次会议决议

Core Viewpoint - Wantai Biological Pharmacy (万泰生物) announced the approval of several proposals during its 14th meeting of the 6th Board of Directors, including the use of idle self-owned funds and idle raised funds for cash management, as well as the establishment of a system for the temporary suspension and exemption of information disclosure [1] Group 1 - The company approved a proposal to use part of its idle self-owned funds for cash management [1] - The company also approved a proposal to use part of its idle raised funds for cash management [1] - A proposal to establish a system for the temporary suspension and exemption of information disclosure was also approved [1]